CAMBRIDGE, Mass. — August 25, 2025 — Leads & Copy — Beam Therapeutics Inc. (Nasdaq: BEAM) will participate in fireside chats at investor conferences, including Citi’s 2025 Biopharma Back to School Conference on Sept. 3 at 4:00 p.m. ET in Boston; the 2025 Wells Fargo Healthcare Conference on Sept. 4 at 1:30 p.m. ET in Boston; and the H.C. Wainwright 27th Annual Global Investment Conference on Sept. 8 at 10:30 a.m. ET in New York. Live webcasts will be available in the investor section of the company’s website and archived for 60 days.
Beam Therapeutics is focused on precision genetic medicines through base editing, with integrated gene editing, delivery, and manufacturing capabilities. The company aims to provide life-long cures to patients suffering from serious diseases.
Holly Manning, Beam Therapeutics, hmanning@beamtx.com
Source: Beam Therapeutics
